Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2006-08-13 14:59:53 UTC |
---|
Update Date | 2022-03-07 02:49:20 UTC |
---|
HMDB ID | HMDB0004238 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Delta-12-Prostaglandin J2 |
---|
Description | Delta-12-Prostaglandin J2 (d12-PGJ2) is the ultimate metabolite of Prostaglandin D2 (PGD2). PGD2 is an unstable molecule and undergoes dehydration to form PGJ2 in aqueous solution, and is then converted to d12-PGJ2, in the presence of serum albumin or plasma. d12-PGJ2 forms a conjugate with the thiol of glutathione (GSH) and GSH suppresses the d12-PGJ2-induced HSP synthesis and subsequent inhibition of cell growth (HSPs are a set of proteins synthesized in response to heat shock or to other environmental stresses). d12-PGJ2 has been shown to stimulate alkaline phosphatase activity and calcification of human osteoblastic cells, the potency of the PGs being comparable to that of 1-a,25-dihydroxy vitamin D. d12-PGJ2 enhances the type-1 collagen synthesis in human osteoblasts during calcification. Thus, d12-PGJ2 modulates osteogenesis through induction of the syntheses of multiple proteins related to mineralization. Considering that PGD2 is a major arachidonate metabolite in bone marrow, d12-PGJ2, may be physiologically involved in the modulation of osteogenesis. d12-PGJ2 induces heme oxygenase, HO-l. Heme oxygenase is a key enzyme in heme catabolism, oxidatively clearing heme to yield biliverdin, iron and carbon monoxide. The biological function of this enzyme is the conversion of potentially toxic heme to bile and the recovery of the iron. Furthermore, carbon monoxide produced on the enzymatic degradation of heme has been suggested to function as a neural messenger. Two isozymes of heme oxygenase, HO-l and HO-2, have been identified. HO-2 is constitutively expressed, while HO-l is drastically induced in response to a variety of stresses, including heavy metals, heat shock and UV irradiation. (PMID: 8777585 )Prostaglandins are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. |
---|
Structure | CCCCC[C@H](O)C\C=C1/[C@@H](C\C=C/CCCC(O)=O)C=CC1=O InChI=1S/C20H30O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,12,14-17,21H,2-3,5-6,8-11,13H2,1H3,(H,23,24)/b7-4-,18-14+/t16-,17-/m0/s1 |
---|
Synonyms | Value | Source |
---|
9-Deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2 | ChEBI | 9-Deoxy-delta(9), delta(12)-13,14-dihydroprostaglandin D2 | ChEBI | 9-Deoxy-delta(9,12)-13,14-dihydro PGD2 | ChEBI | D12-PGJ2 | ChEBI | DDDD-PGD2 | ChEBI | delta(12)-PGJ2 | ChEBI | delta-12-PGJ2 | ChEBI | 9-Deoxy-δ(9), δ(12)-13,14-dihydroprostaglandin D2 | Generator | 9-Deoxy-δ(9,12)-13,14-dihydro PGD2 | Generator | Δ(12)-PGJ2 | Generator | Δ-12-PGJ2 | Generator | Δ-12-prostaglandin J2 | Generator | Prostaglandin J2 | HMDB | (5Z,12E,15S)-15-Hydroxy-11-oxo-prosta-5,9,12-trien-1-Oic acid | MeSH |
|
---|
Chemical Formula | C20H30O4 |
---|
Average Molecular Weight | 334.4498 |
---|
Monoisotopic Molecular Weight | 334.214409448 |
---|
IUPAC Name | (5Z)-7-[(1S,5E)-5-[(3S)-3-hydroxyoctylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid |
---|
Traditional Name | delta-12-prostaglandin J2 |
---|
CAS Registry Number | 87893-54-7 |
---|
SMILES | CCCCC[C@H](O)C\C=C1/[C@@H](C\C=C/CCCC(O)=O)C=CC1=O |
---|
InChI Identifier | InChI=1S/C20H30O4/c1-2-3-6-10-17(21)13-14-18-16(12-15-19(18)22)9-7-4-5-8-11-20(23)24/h4,7,12,14-17,21H,2-3,5-6,8-11,13H2,1H3,(H,23,24)/b7-4-,18-14+/t16-,17-/m0/s1 |
---|
InChI Key | TUXFWOHFPFBNEJ-GJGHEGAFSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as prostaglandins and related compounds. These are unsaturated carboxylic acids consisting of a 20 carbon skeleton that also contains a five member ring, and are based upon the fatty acid arachidonic acid. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Fatty Acyls |
---|
Sub Class | Eicosanoids |
---|
Direct Parent | Prostaglandins and related compounds |
---|
Alternative Parents | |
---|
Substituents | - Prostaglandin skeleton
- Long-chain fatty acid
- Hydroxy fatty acid
- Fatty acid
- Unsaturated fatty acid
- Ketone
- Cyclic ketone
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxide
- Organic oxygen compound
- Alcohol
- Hydrocarbon derivative
- Carbonyl group
- Organooxygen compound
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Delta-12-Prostaglandin J2,1TMS,isomer #1 | CCCCC[C@@H](C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O)O[Si](C)(C)C | 2897.8 | Semi standard non polar | 33892256 | Delta-12-Prostaglandin J2,1TMS,isomer #2 | CCCCC[C@H](O)C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C | 2852.1 | Semi standard non polar | 33892256 | Delta-12-Prostaglandin J2,2TMS,isomer #1 | CCCCC[C@@H](C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C)O[Si](C)(C)C | 2872.9 | Semi standard non polar | 33892256 | Delta-12-Prostaglandin J2,1TBDMS,isomer #1 | CCCCC[C@@H](C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O)O[Si](C)(C)C(C)(C)C | 3135.0 | Semi standard non polar | 33892256 | Delta-12-Prostaglandin J2,1TBDMS,isomer #2 | CCCCC[C@H](O)C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C | 3100.6 | Semi standard non polar | 33892256 | Delta-12-Prostaglandin J2,2TBDMS,isomer #1 | CCCCC[C@@H](C/C=C1/C(=O)C=C[C@@H]1C/C=C\CCCC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C | 3351.8 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Delta-12-Prostaglandin J2 GC-MS (Non-derivatized) - 70eV, Positive | splash10-07d3-7492000000-84e4a524519c7194d3f8 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Delta-12-Prostaglandin J2 GC-MS (2 TMS) - 70eV, Positive | splash10-00g0-9213200000-08bfe6bfadbf91ad015c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Delta-12-Prostaglandin J2 GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 10V, Positive-QTOF | splash10-014r-0159000000-53464c9859e74445f91d | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 20V, Positive-QTOF | splash10-060a-2392000000-33943794bd1acfe51f7a | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 40V, Positive-QTOF | splash10-0l0f-9510000000-1a7d8c281e9a8cb4ffbd | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 10V, Negative-QTOF | splash10-001i-0029000000-c451d3694f1a7a9b2e26 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 20V, Negative-QTOF | splash10-00lr-2279000000-d22b689b69a5a517f619 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 40V, Negative-QTOF | splash10-0a4i-9320000000-ff9d06a5ad9737c57055 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 10V, Positive-QTOF | splash10-00kb-0197000000-f182b500732a4e3e956d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 20V, Positive-QTOF | splash10-00kk-6982000000-88a3e1b2014e2ec05234 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 40V, Positive-QTOF | splash10-0aor-9700000000-354f185276245dda1f97 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 10V, Negative-QTOF | splash10-00lr-0009000000-d47e7da9e96521e61516 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 20V, Negative-QTOF | splash10-00o0-0497000000-11a36dd325ff00d18ecf | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Delta-12-Prostaglandin J2 40V, Negative-QTOF | splash10-0a4l-9630000000-4a75d9847f3fc40011ed | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|
General References | - Fukushima M: Prostaglandin J2--anti-tumour and anti-viral activities and the mechanisms involved. Eicosanoids. 1990;3(4):189-99. [PubMed:2073399 ]
- Hirata Y, Hayashi H, Ito S, Kikawa Y, Ishibashi M, Sudo M, Miyazaki H, Fukushima M, Narumiya S, Hayaishi O: Occurrence of 9-deoxy-delta 9,delta 12-13,14-dihydroprostaglandin D2 in human urine. J Biol Chem. 1988 Nov 15;263(32):16619-25. [PubMed:3053696 ]
- Negishi M, Koizumi T, Ichikawa A: Biological actions of delta 12-prostaglandin J2. J Lipid Mediat Cell Signal. 1995 Oct;12(2-3):443-8. [PubMed:8777585 ]
|
---|